Frank Miedema

发表

Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.

I P Keet, F Miedema, M R Klein, 1994, The Journal of infectious diseases.

Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men.

J J Goedert, I P Keet, F Miedema, 1999, The Journal of infectious diseases.

Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.

J. Drijfhout, C. Melief, S. H. Burg, 1998, The Journal of general virology.

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

F. Miedema, A. Osterhaus, F. de Wolf, 1997, The Journal of general virology.

Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy.

N. Foudraine, S. Danner, M. Klein, 1999, The Journal of infectious diseases.

Long-term survivors of HIV-1 infection.

F. Miedema, M. Klein, Frank Miedema, 1995, Trends in microbiology.

Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.

M. Kersten, D. Baarle, F. Miedema, 1999, Blood.

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.

P. Reiss, N. Foudraine, M. Klein, 1999, AIDS.

Evidence that leukocyte function-associated antigen-1 is involved in recirculation and homing of human lymphocytes via high endothelial venules.

C. Meijer, F. Miedema, R. Scheper, 1988, Journal of immunology.

Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox?

S. H. van der Burg, F. Miedema, M. Klein, 1998, Immunology today.

Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection.

G. Weverling, A. Hoepelman, R H Kauffmann, 1994, The Journal of infectious diseases.